| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2006.01.051 |
| P698 | PubMed publication ID | 16494972 |
| P2093 | author name string | Henry Wilde | |
| Visith Sitprija | |||
| Pakamatz Khawplod | |||
| Chalida Supich | |||
| Sukunya Limusanno | |||
| Siriwan Sirikwin | |||
| Maneerat Benjawongkulchai | |||
| Napha Chiraguna | |||
| Wipaporn Jaijaroensab | |||
| Yongyuth Wangroongsarb | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rabies | Q39222 |
| P1104 | number of pages | 3 | |
| P304 | page(s) | 3084-3086 | |
| P577 | publication date | 2006-02-08 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection | |
| P478 | volume | 24 |
| Q47954549 | A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes |
| Q36538027 | A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods |
| Q90520682 | An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route |
| Q36967140 | Animal Bites and Rabies Prophylaxis in Rural Children: Indian Perspective |
| Q50790061 | Antibody responses after dose-sparing intradermal influenza vaccination. |
| Q36622752 | Case report: Evidence of rise in rabies cases in southern Malawi--better preventative measures are urgently required |
| Q64938804 | Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan. |
| Q35896228 | Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases |
| Q22305940 | Current and future trends in the prevention, treatment and control of rabies |
| Q60191962 | Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines |
| Q27306442 | Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries |
| Q64053474 | Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors |
| Q57926583 | Human rabies post exposure prophylaxis in Bhutan, 2005–2008: Trends and risk factors |
| Q49502107 | Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children |
| Q50115867 | Intradermal delivery for vaccine dose sparing: overview of current issues |
| Q38198122 | Intradermal vaccination for rabies prophylaxis: conceptualization, evolution, present status and future. |
| Q28087074 | Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future |
| Q60191961 | Modelling to inform prophylaxis regimens to prevent human rabies |
| Q50520532 | One clinic visit for pre-exposure rabies vaccination (a preliminary one year study). |
| Q38020852 | Preventative childhood vaccination to rabies |
| Q90192077 | Purified Vero Cell Rabies Vaccine (PVRV, Verorab®): A Systematic Review of Intradermal Use Between 1985 and 2019 |
| Q47225463 | Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults |
| Q42183661 | Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis |
| Q84095733 | The immunogenicity of intradermal influenza vaccination in COPD patients |
| Q57482003 | The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania |
| Q38120923 | Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization. |
Search more.